| Typicality: | 0.350 |
| Saliency: | 0.235 |
| trial → be sponsored by → novartis | 6 |
| trial → be funded by → novartis | 4 |
| trial → be supported by → novartis | 3 |
| negative | neutral | positive |
| 0.039 | 0.752 | 0.209 |
| Raw frequency | 13 |
| Normalized frequency | 0.235 |
| Modifier score | 0.500 |
| Perplexity | 50.528 |